Through JNK/p300 CBP signaling cascades, the trans-differentiation of the EMT pathway is a critical cellular event that controls the induction of cell apoptosis and migration in prostate, breast, and colon cancer cells; further studies are mediated actions in CIL-102-treated CRC cells. This evidence concerns the gene MAPK8 and colorectal carcinoma.